Neogen ($NEOG) Misled Investors on 3M Food Safety Merger and Financial Condition Case
$NEOG investors filed a claim against Neogen Corporation for misleading the market about the success of its $5.3 billion merger with 3M’s Food Safety Division, overstating integration progress, and concealing mounting operational and financial issues.
After disclosing a $461 million impairment, slashing guidance, and losing its CEO, $NEOG dropped over 79% from its post-merger high, including 28% on April 9, 2025.
$NEOG investors can join this case to be notified about potential recovery.
Case Details:
Between January 5, 2023, and June 3, 2025, Neogen repeatedly assured investors that the integration of 3M’s Food Safety unit was progressing as planned. Executives touted “tremendous” execution, synergy realization, and projected strong growth and margin expansion.
In reality, internal issues were spiraling. The company struggled with overlapping systems, supply chain failures, and soaring integration costs. Neogen’s leadership concealed internal control weaknesses and delayed disclosing significant financial consequences.
On January 10, 2025, Neogen reported a $461 million goodwill impairment tied to the merger and lowered its FY25 guidance.
On April 9, 2025, the company reported weak revenues, hiked CapEx expectations, and announced the sudden resignation of its CEO.
Finally, on June 4, 2025, Neogen slashed margin forecasts again amid escalating integration costs and inventory problems.
Based on these events, $NEOG investors filed a claim against Neogen, alleging the company:
It misrepresented the status and success of the 3M merger integration.
It concealed material financial risks, including impairment and margin erosion.
It withheld internal problems and leadership instability from investors.
Investors believe Neogen misled the market to preserve its valuation while the 3M acquisition unraveled internally.